Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Garassino, Marina Chiara, MD, Martelli, Olga, MD, Broggini, Massimo, PhD, Farina, Gabriella, MD, Veronese, Silvio, PhD, Rulli, Eliana, PhD, Bianchi, Filippo, MD, Bettini, Anna, MD, Longo, Flavia, MD, Moscetti, Luca, MD, Tomirotti, Maurizio, MD, Marabese, Mirko, PhD, Ganzinelli, Monica, PhD, Lauricella, Calogero, PhD, Labianca, Roberto, MD, Floriani, Irene, PhD, Giaccone, Giuseppe, MD, Torri, Valter, MD, Scanni, Alberto, MD, Marsoni, Silvia, MD
Published in The lancet oncology (01.09.2013)
Published in The lancet oncology (01.09.2013)
Get full text
Journal Article